Mariner LLC Boosts Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Mariner LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 103.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 491,550 shares of the medical instruments supplier’s stock after purchasing an additional 250,219 shares during the period. Mariner LLC owned approximately 0.25% of DENTSPLY SIRONA worth $9,330,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after buying an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC boosted its position in shares of DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock valued at $275,218,000 after acquiring an additional 348,532 shares during the last quarter. Nuance Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Cooke & Bieler LP increased its position in shares of DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after purchasing an additional 1,794,391 shares during the last quarter. Finally, Pacer Advisors Inc. raised its stake in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $12.83 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average price of $15.72 and a 200-day moving average price of $18.82. The company has a market cap of $2.56 billion, a price-to-earnings ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $31.00.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.99%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on XRAY shares. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Barrington Research cut their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Finally, Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Thirteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $22.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.